Conclusion: Balanced hyperosmolar therapy using 3% HTS and 20% mannitol consecutively resulted in a satisfactory brain relaxation and allowed more hemodynamic stability. Keywords: Balanced, Hyperosmolar, Mannitol, 3% hypertonic saline, Supratentorial tumors. ">
Original Article
Author Details :
Volume : 8, Issue : 2, Year : 2021
Article Page : 221-229
https://doi.org/10.18231/j.ijca.2021.044
Abstract
Background: Both 3% hypertonic saline (3% HTS) and 20% mannitol were proven to be effective in relaxing the brain during supratentorial surgeries. This work aimed to study the effect of consecutive use of both drugs on the brain relaxation score and hemodynamic status during such surgeries.
Materials and Methods: Ninety patients scheduled for supratentorial brain surgeries included in this prospective, randomized and double-blind study. Patients were allocated in three groups; HTS group (n=30) received 3 ml/kg 3% NaCl infusion over 30 minutes, HTS/M group (n=30) received mannitol 20% (1.4 ml/kg) as an infusion over 15 minute followed by 1.5 ml/kg 3% NaCl infused over 15 minutes and M group (n=30) received 3.2 ml/kg mannitol 20% infusion over 30 minutes. Brain relaxation was estimated.
MAP and serum Na level were recorded at baseline and then at 30, 90 and 150 min. Total fluid intake, total urine output and operative time were recorded.
Results: Fluid intake and urine output were the highest with 20% mannitol (p < 0 p=0.862).> Conclusion: Balanced hyperosmolar therapy using 3% HTS and 20% mannitol consecutively resulted in a satisfactory brain relaxation and allowed more hemodynamic stability.
Keywords: Balanced, Hyperosmolar, Mannitol, 3% hypertonic saline, Supratentorial tumors.
How to cite : Elkafrawy S A , Khames M K , Kandeel I M , "Balanced hyperosmolar therapy" using 3% hypertonic saline - 20% mannitol versus an equiosmolar volume of either 3% hypertonic saline or mannitol 20% in supratentorial tumor resection: A new approach to achieve hemodynamic stability. Indian J Clin Anaesth 2021;8(2):221-229
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.